Gastric emptying delay GLP-1 agonists slow the rate at which food leaves the stomach, promoting satiety and reducing post-meal glucose spikes
If tolerance is good and no concerning reactions occur, consider increasing to twice-daily application or moving to a 1 percent concentration
Why Some People Lose Faster Than Others Not all individuals respond to GLP-1 therapy in the same way
Conversely, if a patient presents with pernicious anemia or severe neurological signssuch as intense tingling in the hands, memory loss, or muscle weaknessthe dosage remains the same (usually 1,000 mcg), but the frequency increases significantly
It is part of a class of medications called incretin mimetics, specifically a glucagon-like peptide-1 (GLP-1) receptor agonist
We understand that each patients journey to wellness is unique, and we tailor our treatments to meet your individual needs and preferences